Sanofi-US Services Inc. f/k/a Sanofi-Aventis U.S. Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Sanofi-US Services Inc. f/k/a Sanofi-Aventis U.S. Inc.

Sort by

Viewing results 1‒25 of 76

Digital currencies
The Crypt, updated
...president Bill Clinton and ex-prime minister of the U.K....
August 16, 2023
FT Magazine
The music industry according to super-producer Jimmy Iovine
...If Trent Reznor [of Nine Inch Nails] says ‘Get the f**k out of my way,’ you get the f**k out of his way. Dr Dre said: ‘If you send one of your guys up to my studio they’re not going to make it out....
July 6, 2017
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
Neglected tropical diseases
FT Health: New WHO chief faces tough challenges
...Some countries want to use private services to achieve universal health coverage. Others use public services only. Yet others use a mix of private and public....
May 26, 2017
FT AlphavilleDavid Keohane
The 6am London Cut
...(Reuters) “Exelon, the largest U.S. nuclear operator, has agreed to buy Pepco Holdings Inc. for more than $5.4 billion in cash, according to people familiar with the transaction.”...
April 30, 2014
Retail & Consumer industry
SABMiller leads US corporate bond sale surge
...It was the largest bond sale in the US since March 2011, when Sanofi-Aventis sold $7bn, Dealogic said....
January 11, 2012
US & Canadian companies
Shire leads London’s blue-chip fallers
...Shire had little incentive to fund the extra tests as production at Genzyme, now owned by Sanofi-Aventis, would return to normal later this year, analysts said....
March 15, 2012
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
IPOs
London headlines
...Aventis Pharma seals deal to buy Universal Medicare Aventis Pharma, a part of French drug maker Sanofi has entered into a definitive agreement to acquire Universal Medicare’s marketing and distribution business...
August 25, 2011
US downturn
IT departments must deliver more for less
...For example, Sanofi-Aventis, the French multinational pharmaceutical company, is using Microsoft’s SharePoint to revamp its R&D process....
December 6, 2011
Currencies
AstraZeneca indicted in Serbian corruption case
...The action follows the arrests last year in Belgrade of senior officials at the Serbian Institute for Oncology and Radiology, as well as the heads of the Belgrade offices of AstraZeneca, Roche, Actavis, Sanofi-Aventis...
October 27, 2011
FT AlphavilleGwen Robinson
Sanofi-Genzyme: end of a saga?
...From Market Watch: French pharmaceuticals major Sanofi-Aventis SA confirmed Wednesday it has struck a deal to buy U.S. peer Genzyme Corp....
February 16, 2011
Oil
Deal news boosts Wall Street
...Investors were also awaiting the announcement of a takeover of Genzyme , the US pharmaceuticals company, by its French competitor Sanofi-Aventis....
February 7, 2011
US downturn
S&P 500 reinvigorated by tech strength
...Sanofi-Aventis, the French pharmaceutical group, agreed to pay $20.1bn in cash, or $74 a share, for Genzyme in the biggest takeover in the pharmaceutical sector since 2009....
February 16, 2011
US equities
Deal flurry not enough to inspire US stocks
...Genzyme shares gained 0.7 per cent to $70.30 and US-listed shares in Sanofi added 0.5 per cent to $32.87. Sanofi-Aventis has said it will not raise the offer unless Genzyme’s board is willing to talk....
December 13, 2010
US & Canadian companies
JPMorgan adds legal weight in top-tier reshuffle
...with Sanofi-Aventis on its hostile bid for Genzyme, will become vice-chairman of investment banking....
January 21, 2011
European companies
Sanofi-Aventis in $2.2bn deal with Covance
...Covance will become the sole provider to Sanofi-Aventis of central laboratory services – which collect and analyse samples from patients using experimental drugs in clinical trials – and Sanofi-Aventis will...
October 1, 2010
FT Live
US Decarbonization and Industrial Transition Summit
Securing the resources to build and finance America's clean energy future
Wednesday, 29 MayWashington, D.C., USA
US & Canadian companies
UK chief executives wary of M&A action
...That was the conclusion Chris Viehbacher, chief executive of Sanofi-Aventis, the French pharmaceuticals group, drew at the World Economic Forum in Davos last week as he pursues a $18.5bn (£11.5bn) takeover...
January 31, 2011
Cyber warfare
Wall Street edges higher on flurry of deals
...Shares in Genzyme edged down 0.2 per cent to $69.65while the US-listed shares of Sanofi-Aventis declined by 0.1 per cent to $32.23....
December 20, 2010
UK retail results
Wall Street gains led by energy stocks
...Sanofi-Aventis, the French pharmaceutical group, finally agreed its deal with Genzyme for $20.1bn in the biggest takeover in the pharmaceutical sector since 2009....
February 18, 2011
News in-depthThe Big Read
A sugared pill
...Chris Viehbacher, head of Sanofi-Aventis, the French drugmaker, rejects the suggestion that payments need cause insuperable problems....
March 8, 2011
UK companies
GSK deal reflects philosophy on cutting costs
...This is GSK’s second such deal in recent months and follows another large contracting deal by Sanofi-Aventis last week that will see the French group divest many clinical services to Covance, a US contract...
October 4, 2010
Mergers & Acquisitions
Has the M&A recovery come and gone?
...Earlier this month, after weeks of trying to engage Genzyme in friendly deal talks, Sanofi-Aventis, the French drugs group, officially launched a $18.5bn hostile bid for the US biotechnology company, criticising...
October 19, 2010
US downturn
Healthcare and consumer sectors lead late Wall Street rebound
...US-listed shares in Sanofi-Aventis added 0.3 per cent to $28.38....
August 25, 2010
US downturn
Wall Street rally continues as all sectors post gains
...US-listed shares in Sanofi-Aventis rose 1.6 per cent to $29.82 and GlaxoSmithKline’s US-listed shares lost 0.7 per cent to $36.74. The S&P 500 healthcare index was up 1.4 per cent....
July 26, 2010
US equities
US stocks stage late rally
...Sanofi-Aventis’ US shares fell 4.2 per cent to close at $29.35....
July 23, 2010
US downturn
Poor economic data drag on Wall St
...In deal news, Genzyme fell 0.2 per cent to $70.20 after rising 35 per cent in the last two weeks, as it said it had begun takeover talks with Sanofi-Aventis....
August 3, 2010

Previous pagePage 1 of 4Next page